Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial

Publié dans American Heart Journal. 2015 Dec; 170(6):1061-1069 Auteurs : Nicholls SJ, Lincoff AM, Barter PJ, Brewer HB, Fox KA, Gibson CM, Grainger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Riesmeyer J, Vangerow B, Ruotolo G, Weerakkody GJ, Nissen SE. Article disponible en consultant le site Abstract Background and aim :…

Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction : From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST-Elevation Myocardial Infarction (ACCOAST) study

Publié dans American Heart Journal. 2015 Nov; 170(5):1025-1032 Auteurs : Dudek D, Dziewierz A, Widimsky P, Bolognese L, Goldstein P, Hamm C, Tanguay JF, LeNarz L, Miller DL, Brown E, Ten Berg J, Montalescot G; ACCOAST Investigators. Article disponible en consultant le site Abstract Objectives : We evaluated impact of timing of coronary artery bypass…

Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor : the APTITUDE study

Publié dans Circulation : Cardiovascular Interventions. 2015 Nov; 8(11):e002786 Auteurs : O'Connor SA, Amour J1 Mercadier A, Martin R, Kerneis M, Abtan J, Brugier D, Silvain J, Barthélémy O, Leprince P, Montalescot G, Collet JP; ACTION Study Group. Article disponible en consultant le site Abstract Background and aim : Allogenic platelet transfusions (PT) are administered…